Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
University of Nebraska
Northwestern University
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Canadian Cancer Trials Group
Vanderbilt-Ingram Cancer Center
Mayo Clinic
Swiss Cancer Institute
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
The Cleveland Clinic
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Wake Forest University Health Sciences
Massachusetts General Hospital
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Vanderbilt University Medical Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Celldex Therapeutics
Barbara Ann Karmanos Cancer Institute
Bayer
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Vanderbilt University
Indiana University
Indiana University
City of Hope Medical Center
Columbia University
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey